Package 60505-0251-1

{"route": ["ORAL"], "spl_id": "95820c11-e6e2-4f26-6af9-2cc60ef94c41", "openfda": {"upc": ["0360505025237"], "unii": ["B53E3NMY5C"], "rxcui": ["313412", "313413"], "spl_set_id": ["01c0d3d3-2373-a1b7-822a-80a66291a248"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (60505-0251-1)", "package_ndc": "60505-0251-1", "marketing_start_date": "20040116"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (60505-0251-2)", "package_ndc": "60505-0251-2", "marketing_start_date": "20040116"}, {"sample": false, "description": "150 TABLET in 1 BOTTLE (60505-0251-3)", "package_ndc": "60505-0251-3", "marketing_start_date": "20040116"}], "brand_name": "tizanidine", "product_id": "60505-0251_95820c11-e6e2-4f26-6af9-2cc60ef94c41", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "60505-0251", "generic_name": "tizanidine", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA076533", "marketing_category": "ANDA", "marketing_start_date": "20040116", "listing_expiration_date": "20261231"}